Cutaneous lymphoproliferative disorders research

Cutaneous lymphoproliferative disorders are a heterogeneous group of malignancies in which clonal lymphocytes—most often T cells—accumulate primarily in the skin, with mycosis fungoides and Sézary syndrome representing the most common and extensively studied subtypes. Because these conditions span a wide spectrum from indolent, patch-stage disease to aggressive systemic involvement, accurate classification under frameworks such as the WHO-EORTC system is essential for matching patients to appropriate therapies, which range from skin-directed treatments to systemic agents like bexarotene and denileukin diftitox. Researchers are currently working to resolve why some early-stage cases remain stable for decades while others transform into high-grade lymphomas, and molecular profiling of the genomic landscape of cutaneous T-cell lymphomas is beginning to reveal the driver alterations that may explain this variability. Defining reliable prognostic biomarkers and developing targeted therapies for CD30-positive and other subtypes remain central open challenges in improving long-term survival outcomes.

Works

43,173

Total citations

437,260

Keywords

Cutaneous LymphomasMycosis FungoidesSézary SyndromeEORTC ClassificationT-Cell LymphomaCD30+ Lymphoproliferative Disorders